Genesis Care Hospital San Francisco de Asis
- Address
- Calle de Joaquin Costa, 28, 28002 Madrid, Spain
Neoplasms and Medical Oncology
At Genesis Care Hospital San Francisco de Asis, the oncology research program focuses on cancer care, with studies centered on improving outcomes for patients with cutaneous squamous cell carcinoma and prostate cancer. The trials are designed to evaluate whether new or adjusted treatment approaches can better support disease control after standard therapy.
- Research in cutaneous squamous cell carcinoma is examining whether adding a new adjuvant treatment can help reduce the risk of recurrence after surgery and radiation.
- Clinical work in prostate cancer is assessing treatment effectiveness for men whose cancer has returned after surgery, with a focus on outcomes alongside salvage radiotherapy.
These studies reflect a strong interest in refining cancer treatment strategies and measuring how well they preserve long-term disease-free outcomes.
Male Urogenital Diseases and Prostate Cancer
The site also contributes to research in male urogenital diseases, especially prostate cancer. The trials are exploring how hormone-based treatment choices can influence recovery and longer-term cancer control in patients receiving radiation after recurrence.
- One study is comparing different durations of hormone therapy combined with salvage radiotherapy to see which approach offers better long-term results.
- The research aims to improve treatment effectiveness for recurrent prostate cancer after surgery.
Overall, the program is focused on helping clinicians choose more effective treatment combinations for men with recurrent disease.
Cutaneous Squamous Cell Carcinoma Research
In the field of cutaneous squamous cell carcinoma, the trials are looking at whether a newer supportive cancer therapy can improve disease-free survival after surgery and radiation. This research is aimed at strengthening post-treatment care for patients with high-risk disease.
- Testing whether an added treatment can lower the chance of cancer returning after standard local therapy.
- Supporting better long-term outcomes for patients with high-risk skin cancer.
This area highlights the hospital’s interest in advancing treatment options for challenging skin cancers through careful evaluation of clinical benefit.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Genesis Care Hospital San Francisco de Asis
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Comparison of Short- and Long-term Androgen Deprivation Therapy with Salvage Radiotherapy in Prostate Cancer Recurrence: A Phase III Randomized Trial | Instituto De Investigacion En Oncología Radioterapica FEOR | Phase III | Recruiting | Mar 2023 | — |
IMP list
lock Showing 1 of 5 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bicalutamide | 1 | Unknown | 2023-03-13 | 2023-03-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.